| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. is a 10% Owner at OCUL with holdings across 9 companies. Recent SEC Form 4 filings include 26 buys and 4 sells.
Estimated insider holdings value: $124.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | CDXS Codexis, Inc. | 10% Owner | Buy | 45,000 | $4.69 | $210,994.50 | +0.3% | -43.6% | -65.8% | |
| Nov 1, 2024 | SNWV Sanuwave Health, Inc. | 10% Owner | Buy | 27,868 | $15.75 | $438,902.36 | +1.0% | - | - | |
| Oct 25, 2024 | CDXS Codexis, Inc. | 10% Owner | Buy | 25,000 | $2.91 | $72,720.00 | +0.3% | +71.1% | -7.4% | |
| Oct 23, 2024 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Buy | 10,000 | $7.98 | $79,814.00 | +0.4% | +87.8% | +128.0% | |
| Oct 8, 2024 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Buy | 62,070 | $6.99 | $434,136.74 | +0.7% | +64.3% | +182.8% | |
| Sep 25, 2024 | CDXS Codexis, Inc. | 10% Owner | Buy | 85,000 | $2.93 | $249,146.50 | +0.5% | +71.8% | -17.5% | |
| Sep 23, 2024 | CDXS Codexis, Inc. | 10% Owner | Buy | 1,100,000 | $3.01 | $3,308,034.50 | +6.9% | +68.8% | -15.8% | |
| Sep 18, 2024 | CDXS Codexis, Inc. | 10% Owner | Buy | 61,000 | $3.16 | $192,991.80 | +0.8% | +81.0% | -19.9% | |
| Sep 12, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 158,901 | $1.71 | $271,715.44 | -3.7% | +261.3% | +81.5% | |
| Sep 11, 2024 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Buy | 107,500 | $4.70 | $504,875.00 | +2.0% | +151.4% | +266.8% |